Rare diseases
Investigational molecules
Locations
Back to Germany1 770 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of Atumelnant for Children with Congenital Adrenal Hyperplasia
GermanyA study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer
GermanyA study of coramitug compared to placebo for people with heart failure caused by transthyretin amyloid cardiomyopathy
GermanyStudy of glepaglutide compared to placebo for patients with short bowel syndrome with intestinal failure
GermanyA Study of CND261 for Patients with Active ANCA-Positive Vasculitis That Has Not Responded to Previous Treatments
GermanyA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
GermanyA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
GermanyStudy of Surabgene Lomparvovec Compared to Ranibizumab for Adults with Wet Age-Related Macular Degeneration
GermanyTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
GermanyStudy of oral cladribine compared to placebo for patients with generalized myasthenia gravis
GermanyA study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene
GermanyA Study of SPT-300 Compared to Placebo for Adults with Major Depressive Disorder with or without Anxious Distress
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
